Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT02520284 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02520284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02520284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects With Moderately to Severely Active Ulcerative Colitis
Lead sponsor
Gilead Sciences
Phase
Phase 2/3
Overall status
Terminated
Start date
September 30, 2015
Completion date
November 30, 2016
Enrollment
165 (actual)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis